Skip to main content
An official website of the United States government

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

  • All Headings will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Resources

Staff List

Name, Email, Phone Room Group(s)/Office ID
LeeVan, Elyse, M.D., M.P.H.
elyse.leevan@nih.gov
240-276-7314
5E212 Program Officer | Early Detection 658
McCarty, Larae
larae.mccarty@nih.gov
240-276-5777
5E322 Program Specialist | Community Oncology and Prevention Trials
Early Detection
2611
Miller, Eric, Ph.D.
eric.miller2@nih.gov
240-276-5336
5E230 Program Officer | Early Detection 591
Ong, Mary Jane
maryjane.ong@nih.gov
240-858-3296
5E112 Nurse Consultant | Early Detection 2546
Pinsky, Paul, Ph.D.
paul.pinsky@nih.gov
240-276-7014
5E108 Chief | Early Detection 608
Saxena, Neeraj, Ph.D.
neeraj.saxena@nih.gov
240-276-6302
5E218 Program Officer | Early Detection 622
Zhu, Claire, Ph.D.
claire.zhu@nih.gov
240-276-7013
5E106 Program Officer | Early Detection 645

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Reuland, Daniel S.

Univ Of North Carolina Chapel Hill
United States

Administrative Supplement: CSRN Vanguard Study 3UG1CA286949-02S1 Elyse LeeVan, M.D., M.P.H.
Robbins, Hilary A.

International Agency For Res On Cancer
United States

The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening 5R01CA262164-03 Claire Zhu, Ph.D.
Sant, Shilpa

University Of Illinois At Chicago
United States

Three-dimensional organoid models to study breast cancer progression 5R37CA232209-07 Guillermo Marquez, Ph.D.
Schmidt, Christian Maximillian

Indiana University Indianapolis
United States

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer 5U01CA239522-05 Claire Zhu, Ph.D.
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 5R37CA275916-02 Claire Zhu, Ph.D.
Skates, Steven J

Massachusetts General Hospital
United States

Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls 5U01CA260758-04 Claire Zhu, Ph.D.
Suter, Melissa J

Massachusetts General Hospital
United States

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy 5R01CA255326-03 Guillermo Marquez, Ph.D.
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

Abbreviated MRI for HCC screening in cirrhotic patients 5R01CA249765-05 Guillermo Marquez, Ph.D.
Watt, Gordon Patrick

Netherlands Cancer Institute
United States

Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk 7R37CA284134-02 Claire Zhu, Ph.D.
Zhao, Hua

University Of Virginia
United States

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor 5U01CA260731-03 Claire Zhu, Ph.D.